series-a
Stage
2
Investors
About
Annaida Technologies develops microscale magnetic resonance spectroscopy devices and an AI-driven metabolomic platform for noninvasive, rapid, and affordable embryo analysis to support personalized fertility treatments.
Explore Annaida Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.